Phase 3 study of YM060 in patients with diarrhea-predominant irritable bowel syndrome (d-IBS).
Phase of Trial: Phase III
Latest Information Update: 14 Oct 2015
At a glance
- Drugs Ramosetron (Primary)
- Indications Irritable bowel syndrome
- Focus Therapeutic Use
- 03 Oct 2006 Status change
- 19 Nov 2005 New trial record.